ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/10/2025
Back to search
Official data from USPTO
INTESTINAL DIALYSIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTESTINAL DIALYSIS
ST13
US500000097148493Class
35
Filing
97148493
Registration
7264400
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
09/11/2025
Trademark type
Word
Nice classes
35
Filing date
11/30/2021
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
01/24/2020
First use in commerce
01/24/2020
Drawing code
4
Owner type
16
Owner location
EXTON, PA
Examiner
SCHMIDT, JOHN
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
KIBOW BIOTECH LLC
KIBOW BIOTECH, INC.
Representatives
Kathleen A. Tyrrell LICATA & TYRRELL P.C.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail store services featuring nutritional supplements containing probiotics and prebiotics which eliminate uremic toxins in the body
Publications
History of USPTO decisions and trademark events.
23 publications found
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/02/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/23/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/23/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2023
GNRT
NON-FINAL ACTION E-MAILED
03/24/2023
CNRT
NON-FINAL ACTION WRITTEN
03/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2022
GNRT
NON-FINAL ACTION E-MAILED
09/16/2022
CNRT
NON-FINAL ACTION WRITTEN
09/16/2022
DOCK
ASSIGNED TO EXAMINER
09/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2021
NWAP
NEW APPLICATION ENTERED
12/03/2021
Continuous trademark protection
Get notified about every new filing that threatens INTESTINAL DIALYSIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.